Shilpa Medicare informed that it has received marketing authorization from Portugal, Europe, for Tadalafil Orodispersible Films, 20 mg.

The FDA has shared draft guidance on the design and development of AI-enabled medical devices and marketing submissions for those devices.

Jedd Comiskey, Senior Vice President, Head of Europe, highlights the recent NICE recommendation of LYTENAVA™ (bevacizumab gamma) for the ...

Mr. Ainsworth brings over two decades of industry and market access experience to TonixU.S. Food and Drug Administration (FDA) recently assigned ...

There isn't enough evidence to support the use of Merck & Co/MSD's Keytruda in combination with chemotherapy as a first-line treatment for advanced triple negative breast cancer, according to the ...

As 2025 approaches, the digital marketing landscape is set to experience seismic change. Emerging technologies, particularly artificial intelligence, and shifting consumer expectations mean ...

A report released Oct. 17 by the Senate Homeland Security Committee’s investigative subcommittee scrutinizes some of the nation's largest Medicare Advantage insurers for their use of prior ...

From CMS finalizing a rule aimed at streamlining the process to UnitedHealthcare launching a gold-card program, here are four key prior authorization updates Becker's reported in 2024: 1. A new CMS ...

The answer is in the National Defense Authorization Act, a law passed by Congress in the 2024 fiscal year. Section 2890 of the National Defense Authorization Act, introduced by Republican ...

LONDON, UK I December 16, 2024 I Accord Healthcare Limited (Accord) announces that the European Commission (EC) has granted marketing authorisation for Imuldosa® (development code: DMB-3115), a ...

Search Engine Land » SEO » 13 digital marketing trends you should plan for in 2025 Chat with SearchBot Please note that your conversations will be recorded. Ready for another transformative year ...